Insights Into Mutations Induced Conformational Changes and Rearrangement of Fe2+ Ion in pncA Gene of Mycobacterium tuberculosis to Decipher the Mechanism of Resistance to Pyrazinamide.

Frontiers in Molecular Biosciences
Asma Sindhoo NangrajDong-Qing Wei

Abstract

Pyrazinamide (PZA) is the first-line drug commonly used in treating Mycobacterium tuberculosis (Mtb) infections and reduces treatment time by 33%. This prodrug is activated and converted to an active form, Pyrazinoic acid (POA), by Pyrazinamidase (PZase) enzyme. Mtb resistance to PZA is the outcome of mutations frequently reported in pncA, rpsA, and panD genes. Among the mentioned genes, pncA mutations contribute to 72-99% of the total resistance to PZA. Thus, considering the vital importance of this gene in PZA resistance, its frequent mutations (D49N, Y64S, W68G, and F94A) were investigated through in-depth computational techniques to put conclusions that might be useful for new scaffolds design or structure optimization to improve the efficacy of the available drugs. Mutants and wild type PZase were used in extensive and long-run molecular dynamics simulations in triplicate to disclose the resistance mechanism induced by the above-mentioned point mutations. Our analysis suggests that these mutations alter the internal dynamics of PZase and hinder the correct orientation of PZA to the enzyme. Consequently, the PZA has a low binding energy score with the mutants compared with the wild type PZase. These mutations were also repo...Continue Reading

References

Dec 1, 1993·Proteins·A AmadeiH J Berendsen
May 19, 2004·Proceedings of the National Academy of Sciences of the United States of America·Trinh Xuan HoangAmos Maritan
Feb 1, 2005·FEMS Immunology and Medical Microbiology·Umesh C Chaturvedi, Richa Shrivastava
Jun 28, 2005·Nucleic Acids Research·Dina Schneidman-DuhovnyHaim J Wolfson
Oct 4, 2005·Journal of Computational Chemistry·David A CaseRobert J Woods
Jul 25, 2012·Antimicrobial Agents and Chemotherapy·Karolien StoffelsPablo Bifani
Nov 28, 2013·Bioinformatics·Douglas E V PiresTom L Blundell
Jan 13, 2015·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·A AkhmetovaE Ramanculov
Jan 27, 2015·Methods in Molecular Biology·Sargis Dallakyan, Arthur J Olson
Jun 4, 2015·Emerging Microbes & Infections·Wanliang ShiYing Zhang
Sep 18, 2015·Journal of Clinical Microbiology·Nontuthuko E ManingiP Bernard Fourie
Jul 9, 2013·Journal of Chemical Theory and Computation·Daniel R Roe, Thomas E Cheatham
Sep 10, 2013·Journal of Chemical Theory and Computation·Romelia Salomon-FerrerRoss C Walker
Sep 11, 2012·Journal of Chemical Theory and Computation·Bill R MillerAdrian E Roitberg
Sep 21, 2017·Nature Communications·Adam N YadonAlexander S Pym
Oct 6, 2017·Journal of Cellular Biochemistry·Mansi AggarwalAbhinav Grover
Mar 28, 2018·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Muhammad Tahir KhanMuhammad Tanvir Afzal
Oct 30, 2018·Nucleic Acids Research·Sunghwan KimEvan E Bolton
Nov 28, 2018·Journal of Chemical Information and Modeling·Muhammad JunaidDong-Qing Wei
Nov 30, 2018·Journal of Cellular Biochemistry·Muhammad Tahir KhanDong-Qing Wei
Feb 7, 2020·Scientific Reports·Malancha KarmakarDavid B Ascher
Apr 29, 2020·Journal of Biomolecular Structure & Dynamics·Muhammad JunaidDong-Qing Wei
Jul 4, 2020·Interdisciplinary Sciences, Computational Life Sciences·Abbas KhanDong-Qing Wei

❮ Previous
Next ❯

Software Mentioned

Amber general GAFF )
AMBER
UCSF Chimera
MMPBSA
PYMOL
py
ff14SB
PTRAJ
PMEMD
CPPTRAJ

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.